semaglutide period spotting GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients Does Tirzepatide Affect Your Period?

Wegovy received UK marketing authorisation in 2023, and NICE guidance (TA875) supports its use within the NHS for adults with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities), when provided through specialist weight management services, and for a maximum duration of 2 years

The initial dose is usually lower, gradually increasing to minimize side effects

How to Prevent Hair Loss During Weight Loss If you are using GLP-1 medications and are concerned about hair shedding, there are several proactive steps that may help protect hair health

Evoke and Evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimers disease

As retatrutide isnt approved yet, we cant say for sure

But retinal problems were more commonly associated with the injectable drugs